共 50 条
Protein-Ligand Interaction Analyses with Nuclear Magnetic Resonance Spectroscopy Enhanced by Dissolution Triplet Dynamic Nuclear Polarization
被引:9
|作者:
Miyanishi, K.
[1
,2
]
Sugiki, T.
[3
]
Matsui, T.
[1
]
Ozawa, R.
[1
]
Hatanaka, Y.
[2
]
Enozawa, H.
[4
]
Nakamura, Y.
[4
]
Murata, T.
[4
]
Kagawa, A.
[1
,2
]
Morita, Y.
[4
]
Fujiwara, T.
[3
]
Kitagawa, M.
[1
,2
]
Negoro, M.
[2
,5
,6
]
机构:
[1] Osaka Univ, Grad Sch Engn Sci, Dept Syst Innovat, Div Adv Elect & Opt Sci, Toyonaka, Osaka 5608531, Japan
[2] Osaka Univ, Ctr Quantum Informat & Quantum Biol, Toyonaka, Osaka 5600043, Japan
[3] Osaka Univ, Inst Prot Res, Suita, Osaka 5650871, Japan
[4] Aichi Inst Technol, Fac Engn, Dept Appl Chem, Toyota, Aichi 4700392, Japan
[5] Natl Inst Quantum & Radiol Sci & Technol, Inst Quantum Life Sci, Chiba 2638555, Japan
[6] Osaka Univ, Premium Res Inst Human Metaverse Med WPI PRIMe, Suita, Osaka 5650871, Japan
基金:
日本科学技术振兴机构;
关键词:
CROSS-POLARIZATION;
BINDING;
NMR;
PORPHYRINS;
AFFINITY;
TIMES;
D O I:
10.1021/acs.jpclett.3c01002
中图分类号:
O64 [物理化学(理论化学)、化学物理学];
学科分类号:
070304 ;
081704 ;
摘要:
Solution-state nuclear magnetic resonance spectroscopy(NMR) isa powerful method for the analysis of intermolecular interactionswithin a biomolecular system. However, low sensitivity is one of themajor obstacles of NMR. We improved the sensitivity of solution-state C-13 NMR for the observation of intermolecular interactionsbetween protein and ligand using hyperpolarized solution samples atroom temperature. Eutectic crystals composed of C-13-salicylicacid and benzoic acid doped with pentacene were hyperpolarized bydynamic nuclear polarization using photoexcited triplet electrons,and a C-13 nuclear polarization of 0.72 & PLUSMN; 0.07% wasachieved after dissolution. The binding of human serum albumin and C-13-salicylate was observed with several hundred times sensitivityenhancement under mild conditions. The established (CNMR)-C-13 was applied for pharmaceutical NMR experiments by observationof the partial return of the C-13 chemical shift of salicylateby competitive binding with other non-isotope-labeled drugs.
引用
收藏
页码:6241 / 6247
页数:7
相关论文